Eli Lilly pauses trial of its monoclonal antibody to treat coronavirus because of illness

Drugmaker Eli Lilly said Tuesday it is pausing its trial of a combination antibody treatment for coronavirus for safety reasons. Usually, clinical trials are paused because a volun…